Healthcare
Live Price
Offline$0.5579
+0.00% today
1Y Change
-38.01%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SymBio Pharmaceuticals Limited (SYMQY) is a Healthcare stock with a market cap of $4.52B and listed on OTC. The stock last traded around $0.56 and down 38.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -44.1%, EPS growth of -18.6%, a dividend yield of 0.0%. What stands out right now is revenue -44.1%, EPS -18.6%, free cash flow -38.5% with operating margin -339.6% and ROIC -136.2%. Valuation is more restrained than many high-expectation growth names at price/sales 3.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SYMQY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SYMQY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SYMQY Max Drawdown
-53.12%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SYMQY and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.